Novartis Investigative Site

Sapporo

0 studies enrolling now · 4 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Non-Small Cell Lung Cancer, Uveitis

Studies at this site

• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis — Withdrawn before enrolling
• A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo — Completed